Epilepsy and Neuromodulation—Randomized Controlled Trials
AbstractNeuromodulation is a treatment strategy that is increasingly being utilized in those suffering from drug-resistant epilepsy who are not appropriate for resective surgery. The number of double-blinded RCTs demonstrating the efficacy of neurostimulation in persons with epilepsy is increasing. Although reductions in seizure frequency is common in these trials, obtaining seizure freedom is rare. Invasive neuromodulation procedures (DBS, VNS, and RNS) have been approved as therapeutic measures. However, further investigations are necessary to delineate effective targeting, minimize side effects that are related to chronic implantation and to improve the cost effectiveness of these devices. The RCTs of non-invasive modes of neuromodulation whilst showing much promise (tDCS, eTNS, rTMS), require larger powered studies as well as studies that focus at better targeting techniques. We provide a review of double-blinded randomized clinical trials that have been conducted for neuromodulation in epilepsy. View Full-Text
Share & Cite This Article
Kwon, C.-S.; Ripa, V.; Al-Awar, O.; Panov, F.; Ghatan, S.; Jetté, N. Epilepsy and Neuromodulation—Randomized Controlled Trials. Brain Sci. 2018, 8, 69.
Kwon C-S, Ripa V, Al-Awar O, Panov F, Ghatan S, Jetté N. Epilepsy and Neuromodulation—Randomized Controlled Trials. Brain Sciences. 2018; 8(4):69.Chicago/Turabian Style
Kwon, Churl-Su; Ripa, Valeria; Al-Awar, Omar; Panov, Fedor; Ghatan, Saadi; Jetté, Nathalie. 2018. "Epilepsy and Neuromodulation—Randomized Controlled Trials." Brain Sci. 8, no. 4: 69.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.